Press Release | October 27, 2025
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
Read More
Press Release | October 10, 2025
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Read More
Press Release | September 30, 2025
Star Therapeutics Announces Oversubscribed $125 Million Series D Financing
Read More
Press Release | September 17, 2025
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
Read More
